| Safety and efficacy of atezolizumab/bevacizumab in patients with hepatocellular carcinoma and impaired liver function: a systematic review and meta-analysis A Pasta, F Calabrese, A Jaffe, S Labanca, S Marenco, G Pieri, ... Liver Cancer, 2023 | 3 | 2023 |
| Applying Lyon consensus criteria in the work‐up of patients with extra‐oesophageal symptoms–A multicentre retrospective study F Calabrese, A Pasta, G Bodini, M Furnari, P Zentilin, EG Giannini, ... Alimentary Pharmacology & Therapeutics 59 (9), 1134-1143, 2024 | 2 | 2024 |
| Use of tofacitinib as first or second-line therapy is associated with better outcomes in patients with ulcerative colitis: data from a real-world study A Tursi, G Mocci, L Cingolani, E Savarino, R Pica, A Cocco, M Zippi, ... Expert Opinion on Pharmacotherapy 24 (14), 1649-1656, 2023 | 2 | 2023 |
| Safety and efficacy of venous thromboembolism prophylaxis in patients with cirrhosis: A systematic review and meta‐analysis A Pasta, F Calabrese, S Labanca, S Marenco, G Pieri, MC Plaz Torres, ... Liver International 43 (7), 1399-1406, 2023 | 2 | 2023 |
| Treatment for COVID-19—a cohort study from Northern Italy L Guglielmetti, D Aschieri, I Kontsevaya, F Calabrese, A Donisi, A Faggi, ... Scientific Reports 11 (1), 20964, 2021 | 2 | 2021 |
| Food Intolerances, Food Allergies and IBS: Lights and Shadows A Pasta, E Formisano, F Calabrese, MC Plaz Torres, G Bodini, ... Nutrients 16 (2), 265, 2024 | 1 | 2024 |
| Is global score better than a single histological parameter for assessing microscopic esophagitis? E Marabotto, A Pasta, F Calabrese, G Bodini, M Furnari, EG Giannini, ... Neurogastroenterology & Motility 36 (1), e14685, 2024 | 1 | 2024 |
| Albumin-bilirubin score in non-malignant liver diseases should be properly validated A Pasta, F Calabrese, MCP Torres, G Bodini, M Furnari, EV Savarino, ... World Journal of Gastroenterology 29 (46), 6089, 2023 | 1 | 2023 |
| Association between esophageal motor disorders and pulmonary involvement in patients affected by systemic sclerosis: a retrospective study Y Marten Canavesio, A Pasta, F Calabrese, E Alessandri, M Cutolo, ... Rheumatology International, 1-6, 2023 | 1 | 2023 |
| Is CAD-LT score as a predictor of coronary artery disease following liver transplantation? S Labanca, A Pasta, S Cariati, F Calabrese, G Pieri, MCP Torres, ... Liver Transplantation 30 (5), E28-E29, 2024 | | 2024 |
| Biliary reflux after bariatric surgery and after gastroesophageal surgery for gastroesophageal reflux disease E Marabotto, A Mari, F Calabrese, A Pasta, SD Sheijani, EG Giannini, ... Digestive Medicine Research 7, 2024 | | 2024 |
| Expression of epidermal growth factor receptor (EGFR) in systemic sclerosis patients (SSc) and gastro-oesophageal reflux disease (GORD) A Pasta, F Calabrese, SD Sheijani, M Furnari, EG Giannini, F Grillo, ... Immunology Letters 265, 31-36, 2024 | | 2024 |
| Evaluation of the pathophysiological association between the GERD and OSAS: Esophageal pH-monitoring results beyond Lyon criteria L Barbera, A Pasta, F Calabrese, P Zentilin, M Fragale, M Barbieri, ... Journal of gastroenterology and hepatology, 2024 | | 2024 |
| P1066 The real-life use of the Crohn's disease exclusion diet (CDED) in adults with mild-to-moderate Crohn's disease activity: an interim analysis of an open-label randomized … G Bodini, A Pasta, E Formisano, F Calabrese, M Apollonio, L Pisciotta, ... Journal of Crohn's and Colitis 18 (Supplement_1), i1915-i1915, 2024 | | 2024 |
| P576 Fecal calprotectin could predict clinical and endoscopic response to ustekinumab therapy L Bertani, D Tricò, B Barberio, M Vernero, E Bretto, L Ceccarelli, V Pardi, ... Journal of Crohn's and Colitis 18 (Supplement_1), i1125-i1125, 2024 | | 2024 |
| P603 Comparison of the safety and efficacy of ustekinumab and vedolizumab in patients with Crohn’s disease.-A systematic review and meta-analysis of propensity score matched … G Bodini, F Calabrese, A Pasta, E Marabotto, M Furnari, MG Demarzo, ... Journal of Crohn's and Colitis 18 (Supplement_1), i1170-i1170, 2024 | | 2024 |
| P965 Ulcerative proctitis treated with biologics: is it too hard to treat? L Bertani, D Tricò, B Barberio, E Bretto, L Ceccarelli, F Calabrese, A Pasta, ... Journal of Crohn's and Colitis 18 (Supplement_1), i1753-i1753, 2024 | | 2024 |
| Reduction of Fecal Calprotectin Levels Induced by a Short Course of Escherichia Coli Nissle is Associated with a Lower Likelihood of Disease Flares in Patients with Ulcerative … G Bodini, A Ghezzi, A Pasta, E Marabotto, F Calabrese, C Facchini, ... Journal of Gastrointestinal & Liver Diseases 32 (4), 2023 | | 2023 |
| Systematic review and meta-analysis of safety and efficacy of atezolizumab/bevacizumab in Child-Pugh class B patients with hepatocellular carcinoma A Pasta, F Calabrese, A Jaffe, S Labanca, S Marenco, G Pieri, ... Digestive and Liver Disease 55, S221, 2023 | | 2023 |
| Clopidogrel-Induced Eosinophilic Colitis SD Sheijani, F Calabrese, A Pasta, E Marabotto, G Bodini, M Furnari, ... ACG Case Reports Journal 10 (8), e01118, 2023 | | 2023 |
